Skip to main content
Equibles

Equitable Holdings, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1333986 NEW YORK, NY
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$1,450,451
-$96,363 QoQ
Shares Held
2,920
-15.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#761
of 1,745 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority Sole 72% Shared 0% None 28%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Equitable Holdings, Inc. holds $9,067,537 across 15 Biotechnology names. VRTX ranks #2 (16.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LGND
Ligand Pharmaceuticals Inc
 9,304 $2,940,901
2 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		2,920 $1,450,451
3 REGN
Regeneron Pharmaceuticals, Inc.
 1,747 $1,089,324
4 RVMD
Revolution Medicines, Inc.
 5,140 $962,619
5 CRSP
CRISPR Therapeutics AG
 16,341 $891,238
6 VKTX
Viking Therapeutics, Inc.
 11,000 $429,110
7 EXEL
Exelixis, Inc.
 7,495 $407,802
8 JAZZ
Jazz Pharmaceuticals plc
 1,304 $314,224

All Filings in VRTX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,450,451 2,920
2026-03-31 $1,546,814 3,464
2025-12-31 $983,791 2,170
2025-09-30 $1,002,598 2,560
2025-06-30 $995,912 2,237
2025-03-31 $1,043,332 2,152
2024-12-31 $699,489 1,737
2024-09-30 $910,161 1,957
2024-06-30 $768,232 1,639
2024-03-31 $623,670 1,492
2023-12-31 $572,494 1,407
2023-09-30 $475,012 1,366
2023-06-30 $470,151 1,336
2023-03-31 $477,015 1,514
2022-12-31 $229,002 793
2020-09-30 $487,366 1,791
2020-06-30 $514,429 1,772